NANOG and cancer: HSP90AA1 is a NANOG transcriptional target that contributes to the maintenance of cancer cell stemness, and its overexpression of HSP90AA1 was associated with unfavorable prognosis in breast cancer [112], while the inhibition of HSP90 reduces tumor stemness and promotes antitumor immunity.